MA19778A1 - Procede de preparation d'une nouvelle forme orale de Clometacine. - Google Patents

Procede de preparation d'une nouvelle forme orale de Clometacine.

Info

Publication number
MA19778A1
MA19778A1 MA19998A MA19998A MA19778A1 MA 19778 A1 MA19778 A1 MA 19778A1 MA 19998 A MA19998 A MA 19998A MA 19998 A MA19998 A MA 19998A MA 19778 A1 MA19778 A1 MA 19778A1
Authority
MA
Morocco
Prior art keywords
clometacin
preparation
oral form
new oral
new
Prior art date
Application number
MA19998A
Other languages
English (en)
Inventor
Hercelin Bernard
Nghia Nung Vien
Mary Irene
Original Assignee
Roussel Uclaf Ste Americaine F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf Ste Americaine F filed Critical Roussel Uclaf Ste Americaine F
Publication of MA19778A1 publication Critical patent/MA19778A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA19998A 1982-04-26 1983-04-25 Procede de preparation d'une nouvelle forme orale de Clometacine. MA19778A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207137A FR2525474A1 (fr) 1982-04-26 1982-04-26 Nouvelle forme pharmaceutique orale de clometacine

Publications (1)

Publication Number Publication Date
MA19778A1 true MA19778A1 (fr) 1983-12-31

Family

ID=9273377

Family Applications (1)

Application Number Title Priority Date Filing Date
MA19998A MA19778A1 (fr) 1982-04-26 1983-04-25 Procede de preparation d'une nouvelle forme orale de Clometacine.

Country Status (6)

Country Link
US (1) US4478819A (fr)
FR (1) FR2525474A1 (fr)
IT (1) IT1173705B (fr)
MA (1) MA19778A1 (fr)
OA (1) OA07621A (fr)
WO (1) WO1983003756A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004100A1 (fr) * 1984-03-21 1985-09-26 American Home Products Corporation Capsules pharmaceutiques a liberation entretenue
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
CA1313135C (fr) * 1987-02-09 1993-01-26 The Dow Chemical Company Composition de cholestyramine et procede pour sa preparation
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
US5059177A (en) * 1990-04-19 1991-10-22 Cordis Corporation Triple lumen balloon catheter
SE9003904D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Method for the manufacture of a pharmaceutical dosage form
WO1993007859A1 (fr) * 1991-10-23 1993-04-29 Warner-Lambert Company Nouveaux granules pharmaceutiques et procede de preparation
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
SI9700186B (sl) * 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
TWI224101B (en) * 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
ES2290318T3 (es) * 2001-06-20 2008-02-16 Wyeth Derivados sustituidos de acido indolico como inhibidores del inhibidor del activador del plasminogeno-1 (pai-1).
CA2509170A1 (fr) * 2002-12-10 2004-06-24 Wyeth Derives substitues de l'acide acetique de 3-alkyle et 3-arylalkyle 1h-indol-1-yle en tant qu'inhibiteurs de l'inhibiteur des activateurs du plasminogene (pai-1)
JP2006510673A (ja) * 2002-12-10 2006-03-30 ワイス プラスミノゲンアクティベータインヒビター１（ｐａｉ−１）のインヒビターとしての、アリール、アリールオキシ、および、アルキルオキシ置換１ｈ−インドール−３−イルグリオキシル酸誘導体
UA80453C2 (en) * 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
CN1726190A (zh) * 2002-12-10 2006-01-25 惠氏公司 作为纤溶酶原激活物抑制剂－1(pai－1)的抑制剂的取代3－羰基－1h－吲哚－1－基乙酸衍生物
DE10319483A1 (de) * 2003-04-30 2004-11-18 Brockhues Gmbh & Co. Kg Schnell zerfallendes Pigmentkonzentrat
US7420083B2 (en) * 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7582773B2 (en) * 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7351726B2 (en) * 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7265148B2 (en) * 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7141592B2 (en) * 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7332521B2 (en) * 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7268159B2 (en) * 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7534894B2 (en) * 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7446201B2 (en) * 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7163954B2 (en) * 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7442805B2 (en) * 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7342039B2 (en) * 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
MX2007002177A (es) * 2004-08-23 2007-04-02 Wyeth Corp Acidos de pirrolo-naftilo como inhibidores de pai-1.
CN101039936A (zh) * 2004-08-23 2007-09-19 惠氏公司 作为i－型纤溶酶原激活剂抑制剂(pai－1)调节剂用于治疗血栓形成和心血管疾病的唑基－萘基酸
US7605172B2 (en) 2004-08-23 2009-10-20 Wyeth Thiazolo-naphthyl acids
WO2007022321A2 (fr) * 2005-08-17 2007-02-22 Wyeth Indoles substitues et procedes d'utilisation de ceux-ci

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2211485A (en) * 1940-08-13 Effervescent acetyl salicylic acid
US2540253A (en) * 1949-02-08 1951-02-06 Merck & Co Inc Granulation process
US2999293A (en) * 1957-09-12 1961-09-12 Warner Lambert Pharmaceutical Process of granulating effervescent materials
US3131123A (en) * 1959-03-13 1964-04-28 Lab Francais De Therapeutique Enteric tablets and manufacture thereof
US3136692A (en) * 1961-06-30 1964-06-09 Strong Cobb Arner Inc Effervescent composition containing polyvinylpyrrolidone
CA926085A (en) * 1967-07-07 1973-05-15 W. Sopp Samuel Acetylsalicylic acid solubilizing agent and method of preparing same
FR7337M (fr) * 1968-01-11 1969-10-13
US3495001A (en) * 1968-05-27 1970-02-10 Miles Lab Effervescent compositions of acetylsalicylic acid
BE759520A (fr) * 1969-11-28 1971-04-30 Aspro Nicholas Ltd Compositions d'aspirine
US3764668A (en) * 1970-09-30 1973-10-09 Interx Research Corp Compositions of salts of salicylamide
US3676549A (en) * 1970-09-30 1972-07-11 Alza Corp Administration of alkali metal salts of salicylamide
GB1390683A (en) * 1972-12-18 1975-04-16 Biorex Laboratories Ltd Pharmaceutical composition
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
JPS5135415A (en) * 1974-09-20 1976-03-25 Takeda Chemical Industries Ltd Kokeiseizai no seizoho
US4265847A (en) * 1978-03-30 1981-05-05 Kirby Pharmaceuticals Ltd Tabletting process
FR2444460A1 (fr) * 1978-12-22 1980-07-18 Panoz Donald Nouvelle forme galenique a usage oral, et son procede de preparation
US4344929A (en) * 1980-04-25 1982-08-17 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
JPS5861751A (ja) * 1981-10-09 1983-04-12 白井松新薬株式会社 消臭剤

Also Published As

Publication number Publication date
FR2525474B1 (fr) 1985-02-22
IT1173705B (it) 1987-06-24
FR2525474A1 (fr) 1983-10-28
IT8348149A0 (it) 1983-04-22
WO1983003756A1 (fr) 1983-11-10
US4478819A (en) 1984-10-23
OA07621A (fr) 1985-03-31

Similar Documents

Publication Publication Date Title
MA19778A1 (fr) Procede de preparation d'une nouvelle forme orale de Clometacine.
MA22668A1 (fr) Procede de preparation d'oxamides .
RO86234A (fr) Procede pour la preparation des derives d'acylo0ypurines substitues
FR2498598B1 (fr) Procede de preparation d'urethanes aromatiques
RO79840A (fr) Procede pour la preparation de grenailles stabilisees a teneur d'ammonium
PT75499B (fr) Procede pour la preparation de l'alkanoilanilides
FR2527615B1 (fr) Procede de preparation du 26,26,26,27,27,27-hexafluoro-1a,25-dihydroxycholesterol
RO76562A (fr) Procede pour la preparation des 3-imidazolilbenzo-1,2,4-triazine-1-oxydes
MA19294A1 (fr) Procede de preparation d'imino-diacides substitues.
RO78225A (fr) Procede pour la preparation des 3,4-dihydro-3-oxo-2-quinoxalines
RO91422A (fr) Procede pour la preparation des derives de 1,3-oxazolidin-2-one
RO83099A (fr) Procede pour la preparation d'une pyrrolidinone
BR8206726A (pt) Processo aperfeicoado para a preparacao de 1,2-dicloroetano
FR2513540B1 (fr) Procede de preparation d'une composition malaxee
BE880509A (fr) Procede de preparation de 2',6'-dialkyl-n-alcoxymethyl-2-chloro-acetanilides
FR2525219B1 (fr) Procede pour la preparation de 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxamide-1-1-dioxydes
RO89437A (fr) Procede pour la preparation d'une forme galenique de sulpyride
BE880031A (fr) Procede pour la preparation de 1 alpha, 3 beta-dihydroxy-delta 5-steroides
RO86358A2 (fr) Procede pour la preparation des 1,2,4-triazol-1-yl-propionitryles
FR2508948B1 (fr) Procede pour l'alimentation de machines toronneuses
FR2541670B1 (fr) Procede d'epaississement de boues digerees
FR2549042B1 (fr) Procede pour la preparation de la 3,11-dimethyl-2-nonacosanone
FR2521556B1 (fr) Procede de preparation de 3, 3'-diamino-diphenylsulfones
BE873495A (fr) Procede pour la preparation de la 2,4-difluoro-6-amino-s-triazine
PT80832A (fr) Procede de preparation des nouvelles (amino-1-alkylidemyl)-2-indanediones-1,3 substitues